Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review. | Cancer Manag Res | 2021 | 33603488 | PubTator, text mining | PubMed |
| Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. | Blood Cancer J | 2021 | 33602908 | PubTator, text mining | PubMed |
| C-reactive protein-to-albumin ratio is an independent poor prognostic factor in newly diagnosed chronic lymphocytic leukaemia: A clinical analysis of 322 cases. | Transl Oncol | 2021 | 33582571 | PubTator, text mining | PubMed |
| ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both? | Biomolecules | 2021 | 33573353 | PubTator, text mining | PubMed |
| Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors. | PLoS Pathog | 2021 | 33571304 | PubTator, text mining | PubMed |
| mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. | Nature | 2021 | 33567448 | PubTator, text mining | PubMed |
| Characterization of Artificial Pneumothorax-Unrelated Pyothorax-Associated Lymphoma. | J Oncol | 2021 | 33564306 | PubTator, text mining | PubMed |
| Relapsed Chronic Lymphocytic Leukaemia with Concomitant Extensive Chronic Graft versus Host Disease after Allogeneic Haematopoietic Stem Cell Transplantation Successfully Treated with Oral Venetoclax. | Case Rep Transplant | 2021 | 33552611 | PubTator, text mining | PubMed |
| Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients. | Leukemia | 2021 | 33542480 | PubTator, text mining | PubMed |
| Systematic memory B cell archiving and random display shape the human splenic marginal zone throughout life. | J Exp Med | 2021 | 33538775 | PubTator, text mining | PubMed |
| Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells. | Sci Rep | 2021 | 33536534 | PubTator, text mining | PubMed |
| What do we know about the antibody responses to SARS-CoV-2? | Immunobiology | 2021 | 33524881 | PubTator, text mining | PubMed |
| Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation. | Nat Commun | 2021 | 33510161 | PubTator, text mining | PubMed |
| Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target. | Leukemia | 2021 | 33504942 | PubTator, text mining | PubMed |
| Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL. | Cell Death Differ | 2021 | 33495554 | PubTator, text mining | PubMed |
| HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia. | J Transl Med | 2021 | 33485349 | PubTator, text mining | PubMed |
| High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia. | Leukemia | 2021 | 33483618 | PubTator, text mining | PubMed |
| Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor. | J Immunol | 2021 | 33472907 | PubTator, text mining | PubMed |
The Pivotal Role of Viruses in the Pathogeny of Chronic Lymphocytic Leukemia: Monoclonal (Type 1) IgG K Cryoglobulinemia and Chronic Lymphocytic Leukemia Diagnosis in the Course of a Human Metapneumovirus Infection. | Viruses | 2021 | 33466993 | PubTator, text mining | PubMed |
| The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2021 | 33466695 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=50